In This Article:
As December 2024 unfolds, the U.S. stock market is experiencing notable volatility, with the Dow Jones Industrial Average marking its longest losing streak since 1978 amid anticipation of a Federal Reserve interest rate decision. Despite these fluctuations, growth companies with substantial insider ownership continue to capture investor interest due to their potential for aligned management interests and long-term value creation in uncertain economic environments.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.7% |
| Super Micro Computer (NasdaqGS:SMCI) | 14.4% | 24.3% |
| Duolingo (NasdaqGS:DUOL) | 14.7% | 34.6% |
| On Holding (NYSE:ONON) | 19.1% | 29.4% |
| Clene (NasdaqCM:CLNN) | 21.6% | 59.2% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 81.5% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 13.4% | 66.3% |
| BBB Foods (NYSE:TBBB) | 22.9% | 41.5% |
| Credit Acceptance (NasdaqGS:CACC) | 14.0% | 49% |
| Hesai Group (NasdaqGS:HSAI) | 24.4% | 72.7% |
Here we highlight a subset of our preferred stocks from the screener.
Liquidia
Simply Wall St Growth Rating: ★★★★★☆
Overview: Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs in the United States, with a market cap of $933.54 million.
Operations: The company generates revenue primarily from its pharmaceuticals segment, totaling $15.61 million.
Insider Ownership: 10.6%
Revenue Growth Forecast: 59.6% p.a.
Liquidia is experiencing significant revenue growth, forecasted at 59.6% annually, outpacing the US market's average. Despite past shareholder dilution and current net losses, the company is expected to become profitable within three years. Recent developments include an expanded licensing agreement with Pharmosa Biopharm for L606 in key global markets and ongoing clinical trials for YUTREPIA. These strategic moves could enhance Liquidia's position in treating pulmonary conditions using innovative inhalation technologies.
-
Dive into the specifics of Liquidia here with our thorough growth forecast report.
-
Our valuation report here indicates Liquidia may be overvalued.
Red Cat Holdings
Simply Wall St Growth Rating: ★★★★★☆
Overview: Red Cat Holdings, Inc. operates in the United States drone industry by offering a range of products, services, and solutions, with a market cap of approximately $837.68 million.
Operations: Red Cat Holdings, Inc. generates its revenue through diverse offerings in the U.S. drone sector, encompassing a variety of products, services, and solutions.